Skip to main content

Shattuck Labs, Inc.

STTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001680367

In the last 90 days, Shattuck Labs, Inc. insiders filed 0 open-market purchases and 1 sale; 100 institutions reported holding it in 13F filings for Q2 2026, worth $581.3M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Shattuck Labs, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of STTK: Q1 2023 compared with Q2 2023
MeasureQ1 2023Of which not filed for Q2 2023Q2 2023Change
Holders49142−6
Shares20.3M506.0K20.1M+358.0K (+1.8%)
Value$59.7M$1.49M$62.9M+$4.64M (+8.0%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held Shattuck Labs, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to STTK in Q2 2023
InstitutionSharesValue% of portfolio
Pinnacle Associates Ltd506,040$1.58M0.03%
Prudential Financial Inc14,400$44.9K0.00%
Simplex Trading, LLC285$00.00%

Sold out (9)

Institutions that held Shattuck Labs, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of STTK in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Cloverfields Capital Group, LP45,000$132.3K
Qube Research & Technologies Ltd26,479$77.8K
Susquehanna International Group, LLP24,683$72.6K
Reliant Investment Management, LLC20,000$58.8K
Jane Street Group, LLC19,765$58.1K
Man Group plc–$42.0K
Ergoteles LLC12,839$37.7K
Goldman Sachs Group Inc10,621$31.2K
Denali Advisors LLC9,300$27.3K

Not filed for Q2 2023 yet (1)

Institutions that held Shattuck Labs, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding STTK in Q1 2023 that haven't filed for Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Investment Management of Virginia LLC506,040$1.49M